logo

Sarepta Therapeutics (SRPT)



Trade SRPT now with
  Date
  Headline
3/1/2021 4:35:22 PM Sarepta Therapeutics Q4 Loss/share $2.40 Vs. Loss $3.16 Year Ago
1/13/2021 8:45:41 AM Sarepta,Genevant Enter Research Collaboration For Lipid Nanoparticle-Based Gene Editing Therapeutics
11/5/2020 5:09:38 PM Sarepta Therapeutics Q3 Loss/Shr $2.50 Vs Loss $1.70 Prior Year
9/14/2020 8:41:35 AM Sarepta Therapeutics To Present New Data From Its Most Advanced Gene Therapy Programs
8/11/2020 8:38:43 AM Sarepta, University Of Florida Collaborate To Enable Research For Novel Genetic Medicines
7/2/2020 7:10:00 AM Sarepta Therapeutics Signs Agreement With Hansa Biopharma For Imlifidase
6/26/2020 8:34:24 AM Sarepta Therapeutics Completes Submission Of NDA Seeking Accelerated Approval For Casimersen
6/18/2020 8:39:44 AM Sarepta Therapeutics And Selecta Enter Deal For ImmTOR Immune Tolerance Platform In Neuromuscular Diseases
6/15/2020 11:04:20 AM Sarepta Announces Positive Safety And Efficacy Data From SRP-9001 Micro-Dystrophin Gene Therapy Trial